Yue Wu Selected Research

Acute Coronary Syndrome

1/2023	MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort.
1/2021	Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
1/2021	HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome.
1/2020	Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome.
1/2019	Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
10/2018	Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: A STROBE-compliant observational study.
10/2018	Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
3/2011	The double-faced metabolic and inflammatory effects of standard drug therapy in patients after percutaneous treatment with drug-eluting stent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Wu Research Topics

Disease

186	Neoplasms (Cancer) 07/2024 - 11/2004
72	Inflammation (Inflammations) 05/2024 - 01/2014
34	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2010
31	Infections 04/2024 - 10/2016
31	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2012
27	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2005
24	Hypoxia (Hypoxemia) 11/2023 - 01/2004
21	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2010
21	Atherosclerosis 11/2023 - 02/2010
19	COVID-19 04/2024 - 08/2020
18	Glioma (Gliomas) 05/2024 - 02/2014
18	Sepsis (Septicemia) 04/2024 - 01/2016
18	Carcinogenesis 12/2023 - 05/2008
18	Myocardial Infarction 12/2023 - 10/2011
17	Hemorrhagic Shock 01/2023 - 11/2013
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2024 - 10/2010
16	Hepatocellular Carcinoma (Hepatoma) 07/2024 - 02/2017
16	Hemorrhage 01/2023 - 11/2013
15	Wounds and Injuries (Trauma) 12/2023 - 11/2013
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2016
14	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2024 - 01/2016
14	Fibrosis (Cirrhosis) 03/2024 - 01/2014
14	Lung Neoplasms (Lung Cancer) 09/2023 - 10/2010
14	Cognitive Dysfunction 06/2023 - 03/2014
12	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 08/2011
12	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 05/2015
11	Stomach Neoplasms (Stomach Cancer) 05/2024 - 06/2018
11	Anemia 01/2024 - 01/2004
11	Heart Failure 12/2023 - 07/2013
11	Ischemia 01/2023 - 08/2005
10	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 06/2013
10	Asthma (Bronchial Asthma) 12/2023 - 10/2013
10	Parkinson Disease (Parkinson's Disease) 12/2023 - 07/2019
10	Hypertension (High Blood Pressure) 07/2022 - 04/2014
9	Shock 12/2023 - 01/2016
9	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 10/2010
9	Neuroinflammatory Diseases 03/2023 - 09/2015
9	Brain Injuries (Brain Injury) 03/2023 - 01/2016
9	Glaucoma 01/2023 - 09/2011
9	Stroke (Strokes) 10/2022 - 03/2015
9	Atrial Fibrillation 01/2022 - 12/2016
9	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2017
8	Glioblastoma (Glioblastoma Multiforme) 07/2024 - 11/2016
8	Adenocarcinoma 03/2024 - 11/2018
8	Adenocarcinoma of Lung 01/2024 - 01/2020
8	Body Weight (Weight, Body) 08/2023 - 12/2014
8	Acute Coronary Syndrome 01/2023 - 03/2011
8	Type 2 Diabetes Mellitus (MODY) 07/2022 - 09/2017
7	Septic Shock (Toxic Shock Syndrome) 04/2024 - 01/2016
7	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2020
7	Pneumonia (Pneumonitis) 03/2024 - 10/2021

Drug/Important Bio-Agent (IBA)

81	Proteins (Proteins, Gene)FDA Link 07/2024 - 10/2005
48	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2010
29	LipidsIBA 01/2024 - 02/2015
23	Therapeutic UsesIBA 07/2024 - 01/2010
21	CytokinesIBA 03/2024 - 10/2011
21	Peptides (Polypeptides)IBA 01/2023 - 01/2012
20	MicroRNAs (MicroRNA)IBA 03/2024 - 01/2015
18	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2015
18	EnzymesIBA 10/2023 - 01/2010
18	Apolipoproteins E (ApoE)IBA 01/2023 - 02/2010
17	Long Noncoding RNAIBA 03/2024 - 01/2017
17	Oxygen (Dioxygen)IBA 02/2023 - 09/2011
16	Messenger RNA (mRNA)IBA 12/2023 - 01/2004
15	ApolipoproteinsIBA 01/2021 - 02/2010
13	LipopolysaccharidesIBA 12/2023 - 09/2015
12	AntioxidantsIBA 01/2024 - 01/2016
12	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 05/2013
12	VaccinesIBA 11/2023 - 11/2016
12	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 10/2005
12	AndrogensIBA 01/2019 - 01/2009
11	Retinaldehyde (Retinal)IBA 05/2024 - 02/2015
11	Interleukin-6 (Interleukin 6)IBA 09/2023 - 01/2004
10	InflammasomesIBA 03/2024 - 07/2015
10	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2016
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023 - 01/2004
10	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2017
9	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
9	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 06/2012
9	CateninsIBA 12/2023 - 10/2010
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 10/2011
9	Phosphotransferases (Kinase)IBA 04/2023 - 10/2005
8	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2009
8	Bile Acids and Salts (Bile Acids)IBA 01/2024 - 12/2018
8	CholesterolIBA 01/2024 - 11/2019
8	Peroxidase (Myeloperoxidase)IBA 01/2022 - 12/2014
8	GoldIBA 09/2020 - 11/2016
7	IronIBA 01/2024 - 01/2020
7	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 01/2022
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 01/2018

Therapy/Procedure

120	Therapeutics 07/2024 - 07/2005
24	Immunotherapy 04/2024 - 11/2016
19	Drug Therapy (Chemotherapy) 01/2024 - 10/2010
17	Ligation 04/2024 - 10/2011
13	Transplantation 01/2024 - 01/2009
13	Resuscitation 01/2023 - 11/2013
11	Punctures 04/2024 - 01/2016
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 11/2021
9	Percutaneous Coronary Intervention 01/2022 - 12/2017
8	Radiotherapy 01/2024 - 01/2022